Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04608487
Title	Axi-cel in CNS Lymphoma
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Dana-Farber Cancer Institute
Indications	B-cell lymphoma central nervous system lymphoma primary mediastinal B-cell lymphoma diffuse large B-cell lymphoma
Therapies	Cyclophosphamide + Fludarabine axicabtagene ciloleucel
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Dana Farber Cancer Institute		Boston	Massachusetts	02115	United States	Details
Brigham and Women's Hospital		Boston	Massachusetts	02215	United States	Details

*Shaded cells indicate that there was no data available from clincialtrials.gov for the field